Authors:
Oudmaijer, RD
Palacios, J
Eiroa, C
Davies, JK
de Winter, D
Ferlet, R
Garzon, F
Grady, CA
Cameron, A
Deeg, HJ
Harris, AW
Horne, K
Merin, B
Miranda, LF
Montesinos, B
Mora, A
Penny, A
Quirrenbach, A
Rauer, H
Schneider, J
Solano, E
Tsapras, Y
Wesselius, PR
Citation: Rd. Oudmaijer et al., EXPORT: Optical photometry and polarimetry of Vega-type and pre-main sequence stars, ASTRON ASTR, 379(2), 2001, pp. 564-578
Authors:
Mora, A
Merin, B
Solano, E
Montesinos, B
de Winter, D
Eiroa, C
Ferlet, R
Grady, CA
Davies, JK
Miranda, LF
Oudmaijer, RD
Palacios, J
Quirrenbach, A
Harris, AW
Rauer, H
Cameron, A
Deeg, HJ
Garzon, F
Penny, A
Schneider, J
Tsapras, Y
Wesselius, PR
Citation: A. Mora et al., EXPORT: Spectral classification and projected rotational velocities of Vega-type and pre-main sequence stars, ASTRON ASTR, 378(1), 2001, pp. 116-131
Authors:
Deeg, HJ
Amylon, MD
Harris, RE
Collins, R
Beatty, PG
Feig, S
Ramsay, N
Territo, M
Khan, SP
Pamphilon, D
Leis, JF
Burdach, S
Anasetti, C
Hackman, R
Storer, B
Mueller, B
Citation: Hj. Deeg et al., Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation, BIOL BLOOD, 7(4), 2001, pp. 208-215
Authors:
Storb, R
Blume, KG
O'Donnell, MR
Chauncey, T
Forman, SJ
Deeg, HJ
Hu, WW
Appelbaum, FR
Doney, K
Flowers, MED
Sanders, J
Leisenring, W
Citation: R. Storb et al., Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters, BIOL BLOOD, 7(1), 2001, pp. 39-44
Citation: Z. Li et Hj. Deeg, Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation, LEUKEMIA, 15(3), 2001, pp. 465-467
Authors:
Benito, AI
Milner, LA
Leisenring, W
Deeg, HJ
Woolfrey, AE
Citation: Ai. Benito et al., Absence of major histocompatibility class II expression does not impair hematopoiesis in mice, EXP HEMATOL, 29(9), 2001, pp. 1070-1075
Citation: V. Lesnikov et al., Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes, EXP HEMATOL, 29(4), 2001, pp. 477-489
Authors:
Schuler, US
Renner, UD
Kroschinsky, F
Johne, C
Jenke, A
Naumann, R
Bornhauser, M
Deeg, HJ
Ehninger, G
Citation: Us. Schuler et al., Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation, BR J HAEM, 114(4), 2001, pp. 944-950
Authors:
Jurado, M
Deeg, HJ
Gooley, T
Anasetti, C
Chauncey, T
Flowers, MED
Myerson, D
Storb, R
Appelbaum, FR
Citation: M. Jurado et al., Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia, BR J HAEM, 112(2), 2001, pp. 392-396
Authors:
Deeg, HJ
Blazar, BR
Bolwell, BJ
Long, GD
Schuening, F
Cunningham, J
Rifkin, RM
Abhyankar, S
Briggs, AD
Burt, R
Lipani, J
Roskos, LK
White, JM
Havrilla, N
Schwab, G
Heslop, HE
Citation: Hj. Deeg et al., Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL, BLOOD, 98(7), 2001, pp. 2052-2058
Authors:
Anderson, JE
Tefferi, A
Craig, F
Holmberg, L
Chauncey, T
Appelbaum, FR
Guardiola, P
Callander, N
Freytes, C
Gazitt, Y
Razvillas, B
Deeg, HJ
Citation: Je. Anderson et al., Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis, BLOOD, 98(3), 2001, pp. 586-593
Authors:
Socie, G
Clift, RA
Blaise, D
Devergie, A
Ringden, O
Martin, PJ
Remberger, M
Deeg, HJ
Ruutu, T
Michallet, M
Sullivan, KM
Chevret, S
Citation: G. Socie et al., Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies, BLOOD, 98(13), 2001, pp. 3569-3574
Authors:
Kansu, E
Gooley, T
Flowers, MED
Anasetti, C
Deeg, HJ
Nash, RA
Sanders, JE
Witherspoon, RP
Appelbaum, FR
Storb, R
Martin, PJ
Citation: E. Kansu et al., Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial, BLOOD, 98(13), 2001, pp. 3868-3870
Authors:
Zang, DY
Goodwin, RG
Loken, MR
Bryant, E
Deeg, HJ
Citation: Dy. Zang et al., Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis, BLOOD, 98(10), 2001, pp. 3058-3065
Authors:
Eiroa, C
Garzon, F
Alberdi, A
de Winter, D
Ferlet, R
Grady, CA
Cameron, A
Davies, JK
Deeg, HJ
Harris, AW
Horne, K
Merin, B
Miranda, LF
Montesinos, B
Mora, A
Oudmaijer, R
Palacios, J
Penny, A
Quirrenbach, A
Rauer, H
Schneider, J
Solano, E
Tsapras, Y
Wesselius, PR
Citation: C. Eiroa et al., EXPORT: Near-IR observations of Vega-type and pre-main sequence stars, ASTRON ASTR, 365(2), 2001, pp. 110-114
Authors:
Lesnikova, M
Lesnikov, V
Arrighi, S
Kistler, G
Pierpaoli, W
Deeg, HJ
Citation: M. Lesnikova et al., Upregulation of interleukin-10 and inhibition of alloantigen responses by transferrin and transferrin-derived glycans, J HEMATH ST, 9(3), 2000, pp. 381-392
Authors:
Deeg, HJ
Beckham, C
Loken, MR
Bryant, E
Lesnikova, M
Shulman, HM
Gooley, T
Citation: Hj. Deeg et al., Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome, LEUK LYMPH, 37(3-4), 2000, pp. 405
Citation: Cl. Green et al., Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML), LEUKEMIA, 14(4), 2000, pp. 770-772